期刊文献+

他汀类药物的临床应用 被引量:5

Clinical Application of Statins
下载PDF
导出
摘要 本文回顾总结了临床试验研究他汀类药物在降脂治疗中的作用,如对缺血性心脏病患病率和死亡率的一级预防,对冠心病相关事件的二级预防等,证实他汀类药物可降低胆固醇,减少冠心病事件的危险性。详细介绍了如何合理应用他汀类药物,包括适应症、药物选择、联合用药、非药物治疗、辅助药物治疗等;提出用药物期间安全性检测指标和不良反应监测;最后对他汀类药物进行药效评价和展望。 This paper summarizes the effect of statins in lowering blood lipid through clinical experimental research retrospectively,for example,the primary prevention on morbidity rate and mortality rate of ischemic heart disease and the secondary prevention of coronary heart disease-related events and the like.It confirms that statins can lower cholesterol and reduce the risk of coronary heart disease events.This paper introduces how to use statins rationally in detail,including indication,drug selection,drug combination,non-drug treatment and auxiliary drug treatment.It proposes indexes used to test safety and monitor adverse reactions during medication;it evaluates the effect of statins and provides an outlook in the end.
作者 许利
出处 《保健医学研究与实践》 2012年第3期83-85,88,共4页 Health Medicine Research and Practice
关键词 他汀类药物 降血脂 心血管疾病 安全性 Statins Lowering blood lipid Cardiovascular disease Satety
  • 相关文献

参考文献5

二级参考文献54

  • 1范群雄,张涛,唐雪梅,王小茅,胡勇.瑞舒伐他汀对老年高脂血症高敏C反应蛋白的影响及调脂疗效观察[J].实用心脑肺血管病杂志,2010,18(12):1789-1790. 被引量:11
  • 2吕瑞娟,张运,陈玉国,孙袆,王文君.他汀类药物治疗ALT升高的急性冠状动脉综合征的可行性研究[J].新医学,2006,37(6):368-369. 被引量:16
  • 3Vogt A, Kassner U, Hostalek U, Steinhagen-Thiessen E. Proloaged-release nicotinic acid for the management of dyslipidemia: an update including results from the NAUTILUS study [ J ]. Vascul Health Risk Manag,2007 ,3( 4 ) :467 - 79.
  • 4Knopp R H, Paramsothy P, Atkinson B,Dowdy A. Comprehensive lipid management versus aggressive low-density lipoprotein lowering to reduce cardiovascular risk [ J ]. Am J Cardiol, 2008,101 (Suppl) :48B - 57B.
  • 5Peter Alagona Jr. Beyond LDL cholesterol : the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining afer statin therapy [ J ]. Am J Manag Care,2009,15 : $65 - $73.
  • 6Cziraky M J. The impact of residual CVD risk in the management care setting [ J ]. Am J Manag Care,2009,15 : S74 - S80.
  • 7Robinson J G. Manangement of complex lipid abnormalities with a fixed dose combination of simvastatin and extended release niacin [ J]. Vasc Health Risk Manag,2009,5:31 - 43.
  • 8Taylor A J,Villines T C, Stanek E J, et al. Extended-release niacin or ezetimibe and carotid intima-media thickness [ J ]. N Engl J Med,2009,361:2113 - 22.
  • 9Lamon-Fava S, Diffenderfer M R, Barrett P H, et al. Extended-release niacin alters the metabolism of plasma Apolipoprotein(Apo) A-I and ApoB-containing lipoproteins[ J]. Arterioscler Thromb Vasc Biol,2008,28 : 1672 - 8.
  • 10Pandian A, Arora A, Sperling L S, Khan B V. Targeting mutiple dyslipidemias with fixed combinations-focus on extended release niacin and simvastatin [ J ]. Vasc Health Risk Manag,2008,4 (5) : 1001 -9.

共引文献56

同被引文献36

  • 1胡大一.降脂药物的合理应用[J].老年医学与保健,2005,11(1):5-8. 被引量:20
  • 2梁旭燕,张凤秋.高血脂症的危害和治疗[J].中国疗养医学,2007,16(1):19-20. 被引量:37
  • 3中国成人血脂异常防治指南[J].中华心血管病杂志,2007,35(5):390-419. 被引量:5219
  • 4Gillespie C D, Keenan N L, Miner J B, et al. Screening for lipid disorders among adults-National Health and Nu- trition Examination Survey, United States, 2005- 2008 [J]. Morbidity Mortality Weekly Rep, 2012,6 t (2) : 26.
  • 5Natarajan P, Ray KK, Cannon CP.High-density lipoprote- in and coronary heart disease current and future therapies [J].J Am Coll Cardiol,2010,55(13) : 1 283.
  • 6Kajinami K,Takekoshi N.Cholesterol absorption inhibitoys in development as potential therapeutics[J].Expert Opln Investig Drugs, 2002,21 (3) : 831.
  • 7Lnazu A.Novel therapy for atherosclerosis and inflammatory vascular disease[J].Nippon Rinsho Japan, 2011,69: 105.
  • 8贺同佳.他汀类联合心血管药物治疗63例冠心病的临床效果分析[J].世界最新医学信息文摘(电子版),2014,19:124,126.
  • 9张芙成,张靖瑜,王志方,等.80例服用他汀类降血脂药治疗冠心病的临床观察[J].中国保健营养(上旬刊),2013,23(8):4502-4503.
  • 10韩辉,薛静,张静瑜,徐芳辉,王宇虹.瑞舒伐他汀与阿托伐他汀治疗老年高胆固醇血症的疗效和安全性比较[J].中国新药与临床杂志,2008,27(2):120-123. 被引量:37

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部